NATIONAL VACCINE ADVISORY COMMITTEE

Resolution:

Working Group on Adult Immunization

Adult Immunization - Adverse Events and Liability

Recommendation #2

May 1, 1997

WHEREAS, the cost in morbidity, mortality, and health care dollars of vaccine preventable disease in adults in the United States is substantial; and

WHEREAS, in the 1994 NVAC report, Adult Immunization, emphasis was placed on preserving and strengthening the capacity of the nation's vaccine manufacturers to meet current and future needs for adult vaccines; and

WHEREAS, one strategy in the report to accomplish this recommendation is to explore the advantages and disadvantages of incorporating accepted vaccine-related adverse events which follow adult immunization into the National Vaccine Injury Compensation Program (NVICP); and

WHEREAS, various options for vaccine injury compensation are under consideration in the national plan for Influenza Pandemic Preparedness; and

WHEREAS, a comprehensive analysis of adverse events following administration of adult vaccines, has not been carried out,

Then be it therefore resolved:

The NVAC recommends that the Assistant Secretary for Health give priority to carrying out a comprehensive study and analysis of existing data on adverse events and liability, and how these factors impact adult immunization, the purpose of such an analysis being to guide policy decisions regarding incorporation of adult vaccines within NVICP in a timely manner.

Welcome Center | What's New | Publications | Contact Us

CDC Home | Search | Health Topics A-Z

Last updated: August 8, 2003
URL:

Centers for Disease Control and Prevention
National Vaccine Program Office